Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries-Reference-Cited by-同舟云学术

Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries

Published:2016-01-27 Issue:3 Volume:2 Page:152-167
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:Eur Heart J Cardiovasc Pharmacother

Author:

Danchin Nicolas,Lettino Maddalena,Zeymer Uwe,Widimsky Petr,Bardaji Alfredo,Barrabes Jose A.,Cequier Angel,Claeys Marc J.,De Luca Leonardo,Dörler Jakob,Erlinge David,Erne Paul,Goldstein Patrick,Koul Sasha M.,Lemesle Gilles,Lüscher Thomas F.,Matter Christian M.,Montalescot Gilles,Radovanovic Dragana,Lopez Sendón Jose,Tousek Petr,Weidinger Franz,Weston Clive F. M.,Zaman Azfar,Andell Pontus,Li Jin,Jukema J. Wouter

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/2/3/152/16730223/pvw003.pdf

Reference17 articles.

1. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

3. Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations;Jukema;Eur Heart J Cardiovasc Pharmacother,2015

4. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel – the European MULTIPRAC Registry

5. Standardized Bleeding Definitions for Cardiovascular Clinical Trials

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study;Frontiers in Cardiovascular Medicine;2023-09-08

2. OECD indicator ‘AMI 30-day mortality’ is neither comparable between countries nor suitable as indicator for quality of acute care;Clinical Research in Cardiology;2023-09-08

3. OECD indicator 'AMI 30-day mortality' is neither comparable between countries nor suitable as indicator for quality of acute care;CLIN RES CARDIOL;2023

4. In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project;Thrombosis Research;2022-08

5. Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe;European Heart Journal Supplements;2022-03-30